This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bartlett, M S Articles by Smith, J W Search for Related Content PubMed PubMed Citation Articles by Bartlett, M S Articles by Smith, J W

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1994 August; 38(8): 1834-1837

Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice.

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis 46202.

ABSTRACT

Albendazole, a benzimidazole derivative widely used for treating helminth infections, was successfully used to treat and prevent development of Pneumocystis carinii pneumonia in transtracheally inoculated immunosuppressed mice. For treatment, 3 weeks postinoculation, albendazole at 300 and 600 mg/kg of body weight per day was administered in food for 3 weeks. For prophylaxis, albendazole was begun on the same day as inoculation at 300 mg/kg/day for 7 days, and then the dose was reduced to 150 mg/kg/day for 35 additional days. With these regimens, albendazole was effective both for treatment and prophylaxis. Both dexamethasone-immunosuppressed and L3T4+ monoclonal antibody-immunosuppressed mouse models were used, and albendazole inhibited P. carinii infection in both.

This article has been cited by other articles:

• Rodriguez, M., Fishman, J. A. (2004). Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients. Clin. Microbiol. Rev. 17: 770-782 [Abstract] [Full Text]  
• Walzer, P. D., Ashbaugh, A. (2002). Use of Terbinafine in Mouse and Rat Models of Pneumocystis carinii Pneumonia. Antimicrob. Agents Chemother. 46: 514-516 [Abstract] [Full Text]  
• Cirioni, O., Giacometti, A., Barchiesi, F., Fortuna, M., Scalise, G. (1999). In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. J Antimicrob Chemother 44: 653-659 [Abstract] [Full Text]  
• Fishman, J. A. (1998). Treatment of Infection Due to Pneumocystis carinii. Antimicrob. Agents Chemother. 42: 1309-1314 [Full Text]